gene expression
Canhelp Genomics Partners With Mirxes Singapore to Offer Tumor Origin Identification Testing
The firms will make the Canhelp-Origin tumor identification test available for patients with cancers of unknown origin in some Southeast Asian countries.
Novigenix to Develop Prostate Cancer Liquid Biopsy Test With €1.8M Eurostars Consortium Grant
The company is working with investigators at Radboud University to validate an RNA liquid biopsy test to better tailor therapy in advanced castration-resistant prostate cancer.
Inflammatix Raises $57M in Series E Financing
The company said that it will use the money to support regulatory filings and commercialization of its 30-minute TriVerity Acute Infection and Sepsis Test.
New Data Shore Up Evidence for Paired Tumor Origin, Molecular Testing in Cancer of Unknown Primary
Premium
Biotheranostics' CancerType ID can predict tumor origins for the majority of CUP patients, with reflex biomarker testing finding those eligible for targeted treatment.
Investigators last month published early results, which they believe have set a solid foundation for the independent value of their novel signature.